skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Structure-based design of stabilized recombinant influenza neuraminidase tetramers
Structure-based design of stabilized recombinant influenza neuraminidase tetramers
Material Type:
Article 		Add to My Research

Structure-based design of stabilized recombinant influenza neuraminidase tetramers

Nature communications, 2022-04, Vol.13 (1), p.1825-1825, Article 1825 [Peer Reviewed Journal]

2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. ;This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-29416-z ;PMID: 35383176

Full text available

Citations Cited by
2
First records of the West African torpedo in Cabo Verde Archipelago, eastern Atlantic
First records of the West African torpedo in Cabo Verde Archipelago, eastern Atlantic
Material Type:
Article 		Add to My Research

First records of the West African torpedo in Cabo Verde Archipelago, eastern Atlantic

Oryx, 2022-03, Vol.56 (2), p.172-173 [Peer Reviewed Journal]

Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of Fauna & Flora International ;Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of Fauna & Flora International. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0030-6053 ;EISSN: 1365-3008 ;DOI: 10.1017/S0030605321001836

Full text available

Citations Cited by
3
Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design
Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design
Material Type:
Article 		Add to My Research

Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design

Frontiers in immunology, 2021-06, Vol.12 [Peer Reviewed Journal]

Copyright © 2021 Ellis, Brunette, Crawford, Walls, Pham, Chen, Herpoldt, Fiala, Murphy, Pettie, Kraft, Malone, Navarro, Ogohara, Kepl, Ravichandran, Sydeman, Ahlrichs, Johnson, Blackstone, Carter, Starr, Greaney, Lee, Veesler, Bloom and King 2021 Ellis, Brunette, Crawford, Walls, Pham, Chen, Herpoldt, Fiala, Murphy, Pettie, Kraft, Malone, Navarro, Ogohara, Kepl, Ravichandran, Sydeman, Ahlrichs, Johnson, Blackstone, Carter, Starr, Greaney, Lee, Veesler, Bloom and King ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2021.710263 ;PMID: 34267764

Full text available

Citations Cited by
4
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice
Material Type:
Article 		Add to My Research

Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice

npj vaccines, 2022-05, Vol.7 (1), p.55-55, Article 55 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2059-0105 ;EISSN: 2059-0105 ;DOI: 10.1038/s41541-022-00472-2 ;PMID: 35606518

Full text available

Citations Cited by
5
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
Material Type:
Article 		Add to My Research

Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2

Cell, 2020-11, Vol.183 (5), p.1367-1382.e17 [Peer Reviewed Journal]

2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 The Authors 2020 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.10.043 ;PMID: 33160446

Digital Resources/Online E-Resources

Citations Cited by
6
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Material Type:
Article 		Add to My Research

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

Cell, 2021-10, Vol.184 (21), p.5432-5447.e16 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.09.015 ;PMID: 34619077

Full text available

Citations Cited by
7
Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains
Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains
Material Type:
Article 		Add to My Research

Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains

Proceedings of the National Academy of Sciences - PNAS, 2023-03, Vol.120 (11), p.e2214556120-e2214556120 [Peer Reviewed Journal]

Copyright National Academy of Sciences Mar 14, 2023 ;Copyright © 2023 the Author(s). Published by PNAS. 2023 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2214556120 ;PMID: 36888664

Full text available

Citations Cited by
8
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
Material Type:
Article 		Add to My Research

Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

Nature (London), 2021-06, Vol.594 (7862), p.253-258 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jun 10, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03530-2 ;PMID: 33873199

Full text available

Citations Cited by
9
Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens
Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens
Material Type:
Article 		Add to My Research

Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens

Cell reports. Medicine, 2022-10, Vol.3 (10), p.100780, Article 100780 [Peer Reviewed Journal]

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022 The Author(s) 2022 ;ISSN: 2666-3791 ;EISSN: 2666-3791 ;DOI: 10.1016/j.xcrm.2022.100780 ;PMID: 36206752

Full text available

Citations Cited by
10
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Material Type:
Article 		Add to My Research

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

bioRxiv, 2021-03

2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2021.03.15.435528

Digital Resources/Online E-Resources

Citations Cited by
11
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates
Material Type:
Article 		Add to My Research

Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates

bioRxiv, 2021-02

2021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.biorxiv.org/content/10.1101/2021.02.10.430696v1 ;DOI: 10.1101/2021.02.10.430696

Digital Resources/Online E-Resources

Citations Cited by
12
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2
Material Type:
Article 		Add to My Research

Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2

bioRxiv, 2020-08

2020. This article is published under http://creativecommons.org/licenses/by-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2020.08.11.247395

Digital Resources/Online E-Resources

Citations Cited by
13
Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples
Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples
Material Type:
Article 		Add to My Research

Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples

bioRxiv, 2021-07

2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2021.07.02.450915

Digital Resources/Online E-Resources

Citations Cited by
14
Stabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design
Stabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design
Material Type:
Article 		Add to My Research

Stabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design

bioRxiv, 2021-05

2021. This article is published under https://creativecommons.org/publicdomain/zero/1.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2021.05.15.444222

Digital Resources/Online E-Resources

Citations Cited by

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (9)
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait